IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease

International Immunology

Volumn 19, Issue 9, 2007, Pages 1123-1134

  Perona Wright, Georgia ^a   Anderton, Stephen M ^a   Howie, Sarah E M ^b   Gray, David ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Activation kinetics; Dendritic cells; Immunotherapy; Interleukin 10

Indexed keywords

DENDRITIC CELL VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL TRANSFER; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; T-LYMPHOCYTES; TIME FACTORS;

EID: 34548808554     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm084     Document Type: Article

References (85)

1. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature. 392:245.
2. Steinman, R. M. and Nussenzweig, M. C. 2002. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA. 99:351.
3. Geiger, J. D., Hutchinson, R. J., Hohenkirk, L. F. et al. 2001. Vaccination of pediatric solid tumor patients with tumor lysatepulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res. 61:8513.
4. Jefford, M., Maraskovsky, E., Cebon, J. and Davis, I. D. 2001. The use of dendritic cells in cancer therapy. Lancet Oncol. 2:343.
5. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. and Bhardwaj, N. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233.
6. Rutella, S., Danese, S. and Leone, G. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 108:1435.
7. Megiovanni, A. M., Sanchez, F., Gluckman, J. C. and Rosenzwajg, M. 2004. Double-stranded RNA stimulation or CD40 ligation of monocyte-derived dendritic cells as models to study their activation and maturation process. Eur. Cytokine Netw. 15:126.
8. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
9. Hawiger, D., Inaba, K., Dorsett, Y. et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769.
10. Medzhitov, R., Preston-Hurlburt, P. and Janeway, C. A., Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:394.
11. Banchereau, J., Briere, F., Caux, C. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
12. Reis e Sousa, C. 2006. Dendritic cells in a mature age. Nat. Rev. Immunol. 6:476.
13. d'Ostiani, C. F., Del Sero, G., Bacci, A. et al. 2000. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191:1661.
14. Whelan, M., Harnett, M. M., Houston, K. M., Patel, V., Harnett, W. and Rigley, K. P. 2000. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 164:6453.
15. MacDonald, A. S., Straw, A. D., Bauman, B. and Pearce, E. J. 2001. CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J. Immunol. 167:1982.
16. Balic, A., Harcus, Y., Holland, M. J. and Maizels, R. M. 2004. Selective maturation of dendritic cells by Nippostrongylus brasiliensis-secreted proteins drives Th2 immune responses. Eur. J. Immunol. 34:3047.
17. Lutz, M. and Schuler, G. 2002. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 23:445.
18. Menges, M., Rossner, S., Voigtlander, C. et al. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:15.
19. Reis e Sousa, C., Yap, G., Schulz, O. et al. 1999. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity. 11:637.
20. Langenkamp, A., Messi, M., Lanzavecchia, A. and Sallusto, F. 2000. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311.
21. Fiorentino, D. F., Bond, M. W. and Mosmann, T. R. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
22. Corinti, S., Albanesi, C., la Sala, A., Pastore, S. and Girolomoni, G. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166:4312.
23. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
24. Walmsley, M., Katsikis, P. D., Abney, E. et al. 1996. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39:495.
25. Cannella, B., Gao, Y. L., Brosnan, C. and Raine, C. S. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:735.
26. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
27. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213.
28. Enk, A. H., Angeloni, V. L., Udey, M. C. and Katz, S. I. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 151:2390.
29. Murphy, K. M., Heimberger, A. B. and Loh, D. Y. 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250:1720.
30. Inaba, K., Inaba, M., Romani, N. et al. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
31. Stockinger, B., Zal, T., Zal, A. and Gray, D. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891.
32. Heid, C. A., Stevens, J., Livak, K. J. and Williams, P. M. 1996. Real time quantitative PCR. Genome Res. 6:986.
33. Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J. and Marrack, P. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157:1149.
34. Kalinski, P., Hilkens, C. M., Wierenga, E. A. and Kapsenberg, M. L. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal. Immunol. Today. 20:561.
35. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N. 2000. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423.
36. Kamath, A. T., Pooley, J., O'Keeffe, M. A. et al. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165:6762.
37. Willis, R. A., Kappler, J. W. and Marrack, P. C. 2006. CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl Acad. Sci. USA. 103:12063
38. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944.
39. Banchereau, J., Schuler-Thurner, B., Palucka, A. K. and Schuler, G. 2001. Dendritic cells as vectors for therapy. Cell. 106:271.
40. Steinman, R. M., Pack, M. and Inaba, K. 1997. Dendritic cell development and maturation. Adv. Exp. Med. Biol. 417:1.
41. Morel, A. S., Quaratino, S., Douek, D. C. and Londei, M. 1997. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step. Eur. J. Immunol. 27:26.
42. Faulkner, L., Buchan, G. and Baird, M. 2000. Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrowderived dendritic cells but does impair antigen presentation. Immunology. 99:523.
43. Haase, C., Jorgensen, T. N. and Michelsen, B. K. 2002. Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology. 107:489.
44. Huang, F. P., Platt, N., Wykes, M. et al. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435.
45. Urban, B. C., Willcox, N. and Roberts, D. J. 2001. A role for CD36 in the regulation of dendritic cell function. Proc. Natl Acad. Sci. USA 98:8750.
46. Moser, M., De Smedt, T., Sornasse, T. et al. 1995. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 25:2818.
47. Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M. and Willems, F. 1997. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol. 27:1848.
48. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M. and Kapsenberg, M. L. 1998. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161:2804.
49. Sato, M., Iwakabe, K., Kimura, S. and Nishimura, T. 1999. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines. Immunol. Lett. 67:63.
50. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M., Wierenga, E. A. and Kapsenberg, M. L. 1999. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: Decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162:3231.
51. Okazaki, T., Iwai, Y. and Honjo, T. 2002. New regulatory coreceptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 14:779.
52. Hochweller, K. and Anderton, S. M. 2005. Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo. Eur. J. Immunol. 35:1086.
53. Cella, M., Engering, A., Pinet, V., Pieters, J. and Lanzavecchia, A. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
54. Stoll, S., Delon, J., Brotz, T. M. and Germain, R. N. 2002. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296:1873.
55. Van Gool, S. W., Vandenberghe, P., de Boer, M. and Ceuppens, J. L. 1996. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol. Rev. 153:47.
56. Raftery, M. J., Wieland, D., Gronewald, S., Kraus, A. A., Giese, T. and Schonrich, G. 2004. Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol. 173:3383.
57. Rissoan, M. C., Soumelis, V., Kadowaki, N. et al. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
58. Ludewig, B., Graf, D., Gelderblom, H. R., Becker, Y., Kroczek, R. A. and Pauli, G. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25:1943.
59. Steinman, R. M., Turley, S., Mellman, I. and Inaba, K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411.
60. Lanzavecchia, A. and Sallusto, F. 2001. The instructive role of dendritic cells on T cell responses: Lineages, plasticity and kinetics. Curr. Opin. Immunol. 13:291.
61. Hochrein, H., O'Keeffe, M., Luft, T. et al. 2000. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:823.
62. Grumont, R., Hochrein, H., O'Keeffe, M. et al. 2001. c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:1021.
63. Gillessen, S., Carvajal, D., Ling, P. et al. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist. Eur. J. Immunol. 25:200.
64. Kuchroo, V. K., Das, M. P., Brown, J. A. et al. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80:707.
65. Schweitzer, A. N., Borriello, F., Wong, R. C., Abbas, A. K. and Sharpe, A. H. 1997. Role of costimulators in T cell differentiation: Studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158:2713.
66. Maldonado-Lopez, R., Maliszewski, C., Urbain, J. and Moser, M. 2001. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J. Immunol. 167:4345.
67. Edwards, A. D., Manickasingham, S. P., Sporri, R. et al. 2002. Microbial recognition via toll-like receptor-dependent and - independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169:3652.
68. Dillon, S., Agrawal, A., Van Dyke, T. et al. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172:4733.
69. Takayama, T., Tahara, H. and Thomson, A. W. 1999. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells. Transplantation 68:1903.
70. Gonzalez-Rey, E., Chorny, A., Fernandez-Martin, A., Ganea, D. and Delgado, M. 2006. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 107:3632.
71. De Becker, G., Moulin, V., Tielemans, F. et al. 1998. Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur. J. Immunol. 28:3161.
72. McGuirk, P., McCann, C. and Mills, K. H. 2002. Pathogenspecific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221.
73. Verginis, P., Li, H. S. and Carayanniotis, G. 2005. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol 174:7433.
74. Sporri, R. and Reis e Sousa, C. 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6:163.
75. Heath, W. R. and Villadangos, J. A. 2005. No driving without a license. Nat. Immunol. 6:125.
76. Rea, D., van Kooten, C., van Meijgaarden, K. E., Ottenhoff, T. H., Melief, C. J. and Offringa, R. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95:3162.
77. Albert, M. L., Jegathesan, M. and Darnell, R. B. 2001. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:1010.
78. Nolan, K. F., Strong, V., Soler, D. et al. 2004. IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J. Immunol. 172:2201.
79. Commeren, D. L., Van Soest, P. L., Karimi, K., Lowenberg, B., Cornelissen, J. J. and Braakman, E. 2003. Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells. Immunology 110:188.
80. Skok, J., Poudrier, J. and Gray, D. 1999. Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: A feedback regulation of Th1 development. J. Immunol. 163:4284.
81. Bosio, C. M. and Dow, S. W. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792.
82. Griffin, M. D., Lutz, W., Phan, V. A., Bachman, L. A., McKean, D. J. and Kumar, R. 2001. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptordependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl Acad. Sci. USA 98:6800.
83. Xia, C. Q., Peng, R., Beato, F. and Clare-Salzler, M. J. 2005. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 62:45.
84. Voigtlander, C., Rossner, S., Cierpka, E. et al. 2006. Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J. Immunother. 29:407.
85. Emmer, P. M., van der Vlag, J., Adema, G. J. and Hilbrands, L. B. 2006. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 81:1451.